← Leaderboards
Eugenia Trushina
Mayo Clinic Rochester
$15,385,253
Attributed
$17,966,870
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,966,870 · 7
By mechanism
RF1$10,163,768 · 2
R01$5,955,179 · 3
UH3$1,062,867 · 1
UG3$785,056 · 1
Top collaborators
- Doo-Sup Choi5 shared
- Michael K Lee1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Paul D. Robbins$18,718,334
- Meghan E. McGee-Lawrence$7,512,264
- Petras P Dzeja$3,444,507
- Stephen B Kritchevsky$48,894,177
- James L. Kirkland$27,302,366
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMitochondriaS DiseaseNeuronsIn VivoProteinsMetabolicGeneticFunctional DisorderMolecularBaseMouse ModelOxidation-ReductionPathway InteractionsNerve DegenerationNeurodegenerative DisordersBiological MarkersMitochondrial DysfunctionCognitive FunctionAnimal ModelPre-ClinicalInflammationPharmaceutical PreparationsCells
Grant awards (25)
Mitochondrial Complex I as a Target for Neuroprotection in AD$1,458,379
RF1 · FY2025 · AG · contact PI
Chronic Alcohol Exposure and Pathophysiology of Alzheimer's Disease.$397,500
R01 · FY2024 · AG
Chronic Alcohol Exposure and Pathophysiology of Alzheimer's Disease.$397,500
R01 · FY2023 · AG
Mitochondrial Complex I as a Target for Neuroprotection in AD$2,271,860
RF1 · FY2022 · AG · contact PI
Small Molecule Mitochondria-Targeted Therapeutics for AD$778,431
UH3 · FY2022 · NS · contact PI
Chronic Alcohol Exposure and Pathophysiology of Alzheimer's Disease.$397,500
R01 · FY2022 · AG
Small Molecule Mitochondria-Targeted Therapeutics for AD (Supplement)$284,436
UH3 · FY2022 · NS · contact PI
Small molecule mitochondria-targeted therapeutics for AD$785,056
UG3 · FY2021 · NS · contact PI
Small molecule mitochondria-targeted therapeutics for Huntingtons Disease$535,142
R01 · FY2021 · NS · contact PI
Chronic Alcohol Exposure and Pathophysiology of Alzheimer's Disease.$397,500
R01 · FY2021 · AG
Small molecule mitochondria-targeted therapeutics for Huntingtons Disease$535,142
R01 · FY2020 · NS · contact PI
Chronic Alcohol Exposure and Pathophysiology of Alzheimer's Disease.$397,500
R01 · FY2020 · AG
AMP-Kinase as a target for neuroprotection in AD$3,175,735
RF1 · FY2019 · AG
Small molecule mitochondria-targeted therapeutics for Huntingtons Disease$545,636
R01 · FY2019 · NS · contact PI
Small molecule mitochondria-targeted therapeutics for Huntingtons Disease$545,636
R01 · FY2018 · NS · contact PI
Mitochondrial Complex I as a Target for Neuroprotection in AD$66,462
RF1 · FY2018 · AG · contact PI
Mitochondrial Complex I as a Target for Neuroprotection in AD$3,191,332
RF1 · FY2017 · AG · contact PI
Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders$305,930
R01 · FY2015 · ES · contact PI
Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders$302,870
R01 · FY2014 · ES · contact PI
Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders$157,410
R01 · FY2014 · ES · contact PI
Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders$111,300
R01 · FY2014 · ES · contact PI
Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders$299,811
R01 · FY2013 · ES · contact PI
Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders$16,942
R01 · FY2013 · ES · contact PI
Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders$305,930
R01 · FY2012 · ES · contact PI
Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders$305,930
R01 · FY2011 · ES · contact PI